CHOLESTECH CORPORATION
S-8, 1997-10-17
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SUPERIOR ENERGY SERVICES INC, 8-K, 1997-10-17
Next: CHOLESTECH CORPORATION, S-8, 1997-10-17





        As filed with the Securities and Exchange Commission on October 17, 1997
                                                    Registration No. 333-
================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                           ---------------------------

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      Under
                           the Securities Act of 1933
                           ---------------------------


                             CHOLESTECH CORPORATION
             (Exact name of Registrant as specified in its charter)

      California                                        94-3065493
(State of Incorporation)                    (I.R.S. Employer Identification No.)

                            3347 Investment Boulevard
                            Hayward, California 94545
                                 (510) 732-7200
   (Address and telephone number of Registrant's principal executive offices)
                           ---------------------------

                        1992 EMPLOYEE STOCK PURCHASE PLAN
                            (Full Title of the Plans)
                           ---------------------------

                                Andrea J. Tiller
                          Vice President of Finance and
                             Chief Financial Officer
                             CHOLESTECH CORPORATION
                            3347 Investment Boulevard
                            Hayward, California 94545
                                 (510) 732-7200
            (Name, address and telephone number of agent for service)
                           ---------------------------

                                   Copies to:
                             CHRIS F. FENNELL, ESQ.
                        WILSON SONSINI GOODRICH & ROSATI
                            Professional Corporation
                               650 Page Mill Road
                           Palo Alto, California 94304
                           ---------------------------

<TABLE>
                                                   CALCULATION OF REGISTRATION FEE

<CAPTION>
====================================================================================================================================
                                                            Proposed
   Title of Each Class of                                    Maximum             Proposed Maximum
     Securities to be             Amount to be         Offering Price Per      Aggregate Offering            Amount of
        Registered                 Registered                Share                   Price               Registration Fee
====================================================================================================================================
<S>                              <C>                            <C>                    <C>                    <C>
Common Stock, no par       
value(1)...................      200,000 shares                 $12.625                $2,525,000          $765.15(2)
====================================================================================================================================
<FN>
(1)      Includes Preferred Share Purchase Rights which, prior to the occurrence
         of certain events, will not be exercisable or evidenced separately from
         the Common Stock.
(2)      Calculated  in  accordance  with Rule 457(c)  solely for the purpose of
         computing the amount of the  registration fee based upon the average of
         the high and low price for the Common  Stock as  reported on the Nasdaq
         National Market System on October __, 1997
</FN>
</TABLE>

================================================================================

<PAGE>


     The  contents  of  the  Registrant's   Form  S-8  Registration   Statements
(Registration Nos. 33-52350,  333-04146 and 333-22475) dated September 24, April
26,  1996 and  February  27,  1997,  respectively,  are  incorporated  herein by
reference.


     PART II: INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 8.    Exhibits


 Exhibit
 Number                              Documents
- ---------   --------------------------------------------------------------------
   4.2      1992 Employee Stock Purchase Plan, as amended

   5.1      Opinion of counsel as to legality of securities being registered

  23.1      Consent of Independent Accountants

  23.2      Consent of Counsel (contained in Exhibit 5.1)

  24.1      Power of Attorney (see page 3)

                                       -2-

<PAGE>


                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant,
Cholestech  Corporation,  a corporation organized and existing under the laws of
the State of California,  certifies  that it has  reasonable  grounds to believe
that it meets all of the requirements for filing on Form S-8 and has duly caused
this  Registration  Statement  to be  signed on its  behalf by the  undersigned,
thereunto duly authorized,  in the City of Hayward, State of California, on this
17th day of October, 1997.


                                             CHOLESTECH CORPORATION



                                             By:   /s/ WARREN E. PINCKERT II
                                                  ------------------------------
                                                   Warren E. Pinckert II
                                                   President and Chief Executive
                                                   Officer


                                POWER OF ATTORNEY

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears  below  constitutes  and  appoints  Warren E.  Pinckert II and Andrea J.
Tiller, jointly and severally, his or her attorneys-in-fact, each with the power
of  substitution,  for  him or her  in any  and  all  capacities,  to  sign  any
amendments to this Registration Statement on Form S-8 and to file the same, with
exhibits  thereto  and  other  documents  in  connection  therewith,   with  the
Securities  and Exchange  Commission,  hereby  ratifying and confirming all that
each of said  attorneys-in-fact,  or his  substitute or  substitutes,  may do or
cause to be done by virtue hereof.

<TABLE>
     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
Registration  Statement  has  been  signed  by  the  following  persons  in  the
capacities and on the dates indicated.


<CAPTION>
                  Signature                                        Title                                  Date 
- ------------------------------------------     ------------------------------------------------     -----------------------
<S>                                            <C>                                                  <C>
/s/ WARREN E. PINCKERT II                      President and Chief Executive Officer                October 17, 1997
- -------------------------------                (Principal Executive Officer)
(Warren E. Pinckert II)  

/s/ ANDREA J. TILLER                           Vice President of  Finance and Chief                 October 17, 1997
- -------------------------------                Financial Officer (Principal Financial and
(Andrea J. Tiller)                             Accounting Officer)

/s/ HARVEY S. SADOW                            Chairman of the Board                                October 17, 1997
- -------------------------------
(Harvey S. Sadow, Ph.D.)

/s/ JOHN L. CASTELLO                           Director                                             October 17, 1997
- -------------------------------
(John L. Castello)

/s/ H.R. SHEPHERD                              Director                                             October 17, 1997
- -------------------------------
(H.R. Shepherd)

/s/ JOSEPH BUCHMAN                             Director                                             October 17, 1997
- -------------------------------
(Joseph Buchman M.D.)
</TABLE>

                                                             -3-

<PAGE>


                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549



                         -----------------------------
                                    EXHIBITS
                         -----------------------------

                       Registration Statement on Form S-8

                             CHOLESTECH CORPORATION

                                October 17, 1997


                                       -4-

<PAGE>


                             CHOLESTECH CORPORATION

                       REGISTRATION STATEMENT ON FORM S-8

                                INDEX TO EXHIBITS

                                                               Page Number Under
 Exhibit                                                          Sequential
 Number                              Description               Numbering System
- --------------   -------------------------------------------   -----------------
4.2              1992  Employee  Stock Purchase Plan,
                 as amended                                            8

5.1              Opinion of counsel as to legality of
                 securities     being      registered

23.1             Consent of Independent Accountants

23.2             Consent   of  Counsel (contained in
                 Exhibit 5.1)

24.1             Power  of  Attorney   (contained on
                 page 3)

                                       -5-


                             CHOLESTECH CORPORATION

                        1992 EMPLOYEE STOCK PURCHASE PLAN

                     Amended Effective as of August 23, 1995
                 Further Amended Effective As of August 22, 1997


         The following  constitute  the  provisions  of the 1992 Employee  Stock
Purchase Plan of Cholestech Corporation

         1.  Purpose.  The  purpose of the Plan is to provide  employees  of the
Company and its Designated  Subsidiaries  with an opportunity to purchase Common
Stock of the Company through accumulated payroll deductions. It is the intention
of the Company to have the Plan qualify as an  "Employee  Stock  Purchase  Plan"
under  Section  423 of the  Internal  Revenue  Code of  1986,  as  amended.  The
provisions  of the Plan,  accordingly,  shall be  construed  so as to extend and
limit participation in a manner consistent with the requirements of that section
of the Code.

         2. Definitions.

            (a) "Board" shall mean the Board of Directors of the Company.

            (b) "Code" shall mean the Internal Revenue Code of 1986, as amended.

            (c) "Common Stock" shall mean the Common Stock of the Company.

            (d)  "Company"  shall  mean  Cholestech  Corporation,  a  California
corporation.

            (e) "Compensation" shall mean all base straight time gross earnings,
exclusive of payments  for  overtime,  shift  premium,  incentive  compensation,
incentive payments, bonuses, commissions and other compensation.

            (f) "Designated Subsidiaries" shall mean the Subsidiaries which have
been  designated  by the  Board  from  time to time in its  sole  discretion  as
eligible to participate in the Plan.

            (g)  "Employee"  shall mean any individual who is an employee of the
Company  for  purposes  of  tax  withholding  under  the  Code  whose  customary
employment with the Company or any Designated Subsidiary is at least twenty (20)
hours per week and more than five (5) months in any calendar  year. For purposes
of the Plan, the employment  relationship  shall be treated as continuing intact
while the individual is on sick leave or other leave of absence  approved by the
Company. Where the period of leave exceeds 90 days and the individual's right to
reemployment is not guaranteed either by statute or by contract,  the employment
relationship will be deemed to have terminated on the 91st day of such leave.



                                       

<PAGE>



            (h)  "Enrollment  Date"  shall  mean the first day of each  Offering
Period.

            (i) "Exercise Date" shall mean the last day of each Offering Period.

            (j) "Fair  Market  Value" shall mean,  as of any date,  the value of
Common Stock determined as follows:

                (1) If the  Common  Stock is  listed  on any  established  stock
exchange or a national market system,  including without limitation the National
Market System of the National Association of Securities Dealers,  Inc. Automated
Quotation  ("NASDAQ")  System,  its Fair Market  Value shall be the closing sale
price for the Common Stock (or the mean of the closing bid and asked prices,  if
no sales were  reported),  as quoted on such  exchange (or the exchange with the
greatest  volume  of  trading  in  Common  Stock)  or system on the date of such
determination,  as reported in The Wall Street  Journal or such other  source as
the Board deems reliable, or;

                (2) If the Common Stock is quoted on the NASDAQ  system (but not
on the National  Market System  thereof) or is regularly  quoted by a recognized
securities  dealer but selling  prices are not  reported,  its Fair Market Value
shall be the mean of the  closing bid and asked  prices for the Common  Stock on
the date of such  determination,  as reported in The Wall Street Journal or such
other source as the Board deems reliable, or;

                (3) In the  absence  of an  established  market  for the  Common
Stock,  the Fair Market Value  thereof  shall be determined in good faith by the
Board.

            (k) "Offering  Period" shall mean a period of approximately  six (6)
months,  commencing  on  the  first  Trading  Day  on  or  after  January  1 and
terminating  on the last Trading Day in the period ending the following June 30,
or commencing on the first Trading Day on or after July 1 and terminating on the
last Trading Day in the period ending the following December 31, during which an
option granted  pursuant to the Plan may be exercised.  The duration of Offering
Period may be changed pursuant to Section 4 of this Plan.

            (l) "Plan" shall mean this Employee Stock Purchase Plan.

            (m)  "Purchase  Price" shall mean an amount equal to 85% of the Fair
Market  Value  of a share  of  Common  Stock  on the  Enrollment  Date or on the
Exercise Date, whichever is lower.

            (n)  "Reserves"  shall  mean the  number of  shares of Common  Stock
covered by each option under the Plan which have not yet been  exercised and the
number of shares of Common Stock which have been  authorized  for issuance under
the Plan but not yet placed under option.

            (o) "Subsidiary" shall mean a corporation,  domestic or foreign,  of
which  not less  than 50% of the  voting  shares  are held by the  Company  or a
Subsidiary, whether or not such corporation now exists or is hereafter organized
or acquired by the Company or a Subsidiary.



                                       -2-

<PAGE>



            (p) "Trading Day" shall mean a day on which national stock exchanges
and the National  Association of Securities Dealers Automated Quotation (NASDAQ)
System are open for trading.

         3. Eligibility.

            (a) Any Employee (as defined in Section 2(g)), who shall be employed
by the  Company  on a given  Enrollment  Date and who has been  employed  by the
Company for at least three (3) months  shall be eligible to  participate  in the
Plan. Notwithstanding the foregoing,  however, any Employee shall be eligible to
participate in the Plan who was employed by the Company as of the effective date
of a registration  statement  filed with the Securities and Exchange  Commission
for the initial offering of shares of Common Stock of the Company to the public.

            (b) Any provisions of the Plan to the contrary  notwithstanding,  no
Employee  shall  be  granted  an  option  under  the  Plan  (i) to  the  extent,
immediately  after the grant,  such  Employee  (or any other  person whose stock
would be  attributed to such  Employee  pursuant to Section  424(d) of the Code)
would own  capital  stock of the  Company  and/or  hold  outstanding  options to
purchase such stock  possessing  five percent (5%) or more of the total combined
voting  power or value of all classes of the capital  stock of the Company or of
any Subsidiary,  or (ii) to the extent his or her rights to purchase stock under
all employee stock purchase plans of the Company and its  subsidiaries to accrue
at a rate which exceeds  Twenty-Five  Thousand Dollars  ($25,000) worth of stock
(determined  at the fair  market  value of the shares at the time such option is
granted) for each calendar year in which such option is outstanding at any time.

         4.  Offering  Periods.  The Plan shall be  implemented  by  consecutive
Offering Periods with a new Offering Period  commencing on the first Trading Day
on or after  January 1 and July 1 each year,  or on such other date as the Board
shall determine,  and continuing  thereafter until terminated in accordance with
Section 19 hereof.  The Board  shall  have the power to change the  duration  of
Offering  Periods  (including  the  commencement  dates thereof) with respect to
future  offerings  without  shareholder  approval if such change is announced at
least fifteen (15) days prior to the scheduled  beginning of the first  Offering
Period to be affected thereafter.

         5. Participation.

            (a) An eligible  Employee  may become a  participant  in the Plan by
completing a subscription  agreement  authorizing payroll deductions in the form
of Exhibit A to this Plan and  filing it with the  Company's  payroll  office at
least five (5) business days prior to the applicable  Enrollment Date,  unless a
later  time for filing the  subscription  agreement  is set by the Board for all
eligible Employees with respect to a given Offering Period.

            (b) Payroll deductions for a participant shall commence on the first
payroll  following the Enrollment  Date and shall end on the last payroll in the
Offering  Period  to which  such  authorization  is  applicable,  unless  sooner
terminated by the participant as provided in Section 10 hereof.


                                       -3-

<PAGE>



         6. Payroll Deductions.

            (a)  At the  time  a  participant  files  his  or  her  subscription
agreement, he or she shall elect to have payroll deductions made on each pay day
during the Offering  Period in an amount not exceeding  fifteen percent (15%) of
the  Compensation  which he or she  receives on each pay day during the Offering
Period,  and the aggregate of such payroll deductions during the Offering Period
shall not exceed fifteen percent (15%) of the participant's  Compensation during
said Offering Period.

            (b) All payroll  deductions made for a participant shall be credited
to his or her account  under the Plan and will be withheld in whole  percentages
only. A participant may not make any additional payments into such account.

            (c) A participant may not change his or her rate of participation in
the  Plan  during  an  Offering  Period,  but  may  change  his or her  rate  of
participation  with  respect  to any  future  Offering  Period  by  filing a new
subscription  agreement  with the  Company's  payroll  office at least  five (5)
business days prior to the commencement of the Offering Period to which the rate
change shall apply; provided, however, that a participant may discontinue his or
her  participation  in the Plan at any time as provided in Section 10 hereof.  A
participant's  subscription  agreement  shall  remain in effect  for  successive
Offering Periods unless terminated as provided in Section 10 hereof.

            (d) Notwithstanding the foregoing, to the extent necessary to comply
with Section  423(b)(8) of the Code and Section  3(b)  hereof,  a  participant's
payroll  deductions  may be  decreased  to 0% at such time  during any  Offering
Period which is scheduled to end during the current  calendar year (the "Current
Offering  Period")  that the  aggregate  of all  payroll  deductions  which were
previously  used to  purchase  stock under the Plan in a prior  Offering  Period
which ended during that  calendar year plus all payroll  deductions  accumulated
with respect to the Current  Offering Period equal $21,250.  Payroll  deductions
shall  recommence  at the  rate  provided  in  such  participant's  subscription
agreement at the  beginning of the first  Offering  Period which is scheduled to
end in the following  calendar  year,  unless  terminated by the  participant as
provided in Section 10 hereof.

            (e) At the time the option is exercised,  in whole or in part, or at
the time some or all of the  Company's  Common  Stock  issued  under the Plan is
disposed of, the  participant  must make  adequate  provision  for the Company's
federal, state, or other tax withholding  obligations,  if any, which arise upon
the exercise of the option or the  disposition of the Common Stock. At any time,
the Company may, but will not be obligated to,  withhold from the  participant's
compensation the amount necessary for the Company to meet applicable withholding
obligations, including any withholding required to make available to the Company
any tax  deductions or benefits  attributable  to sale or early  disposition  of
Common Stock by the Employee.

         7. Grant of Option.  On the  Enrollment  Date of each Offering  Period,
each eligible Employee participating in such Offering Period shall be granted an
option  to  purchase  on the  Exercise  Date of  such  Offering  Period  (at the
applicable  Purchase  Price) up to a number of  shares of the  Company's  Common
Stock  determined by dividing such  Employee's  payroll  deductions  accumulated
prior to such Exercise Date and retained in the Participant's  account as of the
Exercise Date by the


                                       -4-

<PAGE>



applicable  Purchase  Price;  provided  that in no event  shall an  Employee  be
permitted to purchase  during each Offering  Period more than a number of Shares
determined  by  dividing  $12,500  by the  Fair  Market  Value of a share of the
Company's  Common Stock on the Enrollment  Date, and provided  further that such
purchase shall be subject to the  limitations  set forth in Sections 3(b) and 12
hereof.  Exercise  of the option  shall  occur as  provided in Section 8 hereof,
unless the  participant has withdrawn  pursuant to Section 10 hereof,  and shall
expire on the last day of the Offering Period.

         8. Exercise of Option.  Unless a participant withdraws from the Plan as
provided in Section 10 hereof, his or her option for the purchase of shares will
be exercised  automatically on the Exercise Date, and the maximum number of full
shares  subject  to  option  shall  be  purchased  for such  participant  at the
applicable  Purchase Price with the accumulated payroll deductions in his or her
account.  No  fractional  shares  will  be  purchased;  any  payroll  deductions
accumulated  in a  participant's  account which are not sufficient to purchase a
full share  shall be retained in the  participant's  account for the  subsequent
Offering Period, subject to earlier withdrawal by the participant as provided in
Section 10 hereof.  Any other monies left over in a participant's  account after
the Exercise Date shall be returned to the  participant.  During a participant's
lifetime,  a participant's  option to purchase  shares  hereunder is exercisable
only by him or her.

         9.  Delivery.  As promptly as  practicable  after each Exercise Date on
which a purchase of shares  occurs,  the Company  shall  arrange the delivery to
each  participant,  as  appropriate,  of a certificate  representing  the shares
purchased upon exercise of his or her option.

         10. Withdrawal; Termination of Employment.

            (a) A participant may withdraw all but not less than all the payroll
deductions  credited to his or her  account and not yet used to exercise  his or
her option under the Plan at any time by giving written notice to the Company in
the form of Exhibit B to this Plan. All of the participant's  payroll deductions
credited to his or her account will be paid to such  participant  promptly after
receipt of notice of withdrawal and such  participant's  option for the Offering
Period will be automatically  terminated,  and no further payroll deductions for
the purchase of shares will be made during the Offering Period. If a participant
withdraws from an Offering  Period,  payroll  deductions  will not resume at the
beginning of the succeeding  Offering Period unless the participant  delivers to
the Company a new subscription agreement.

            (b) Upon a  participant's  ceasing to be an Employee  (as defined in
Section 2(g) hereof),  for any reason,  including by virtue of him or her having
failed to remain an Employee  of the Company for at least  twenty (20) hours per
week during an Offering Period in which the Employee is a participant, he or she
will be  deemed  to have  elected  to  withdraw  from the  Plan and the  payroll
deductions credited to such participant's account during the Offering Period but
not yet used to exercise the option will be returned to such  participant or, in
the case of his or her death,  to the person or persons  entitled  thereto under
Section  14  hereof,  and  such  participant's   option  will  be  automatically
terminated.



                                       -5-

<PAGE>



            (c) A participant's withdrawal from an Offering Period will not have
any effect upon his or her  eligibility to participate in any similar plan which
may hereafter be adopted by the Company or in succeeding  Offering Periods which
commence after the termination of the Offering Period from which the participant
withdraws.

         11. Interest.  No interest shall accrue on the payroll  deductions of a
participant in the Plan.

         12. Stock.

            (a) The maximum number of shares of the Company's Common Stock which
shall be made available for sale under the Plan shall be 400,000 shares, subject
to  adjustment  upon  changes in  capitalization  of the  Company as provided in
Section 18 hereof. If on a given Exercise Date the number of shares with respect
to which options are to be exercised exceeds the number of shares then available
under the Plan,  the  Company  shall  make a pro rata  allocation  of the shares
remaining  available for purchase in as uniform a manner as shall be practicable
and as it shall determine to be equitable.

            (b) The participant  will have no interest or voting right in shares
covered by his option until such option has been exercised.

            (c) Shares to be delivered to a  participant  under the Plan will be
registered in the name of the  participant or in the name of the participant and
his or her spouse.

         13. Administration.

            (a) Administrative Body. The Plan shall be administered by the Board
or a committee of members of the Board appointed by the Board.  The Board or its
committee  shall have full and  exclusive  discretionary  authority to construe,
interpret  and  apply the terms of the Plan,  to  determine  eligibility  and to
adjudicate all disputed claims filed under the Plan. Every finding, decision and
determination  made by the  Board or its  committee  shall,  to the full  extent
permitted by law, be final and binding  upon all  parties.  Members of the Board
who are eligible  Employees are permitted to participate  in the Plan,  provided
that:

                (1) Members of the Board who are eligible to  participate in the
Plan may not vote on any matter affecting the  administration of the Plan or the
grant of any option pursuant to the Plan.

                (2) If a Committee is  established  to  administer  the Plan, no
member of the Board who is eligible to  participate  in the Plan may be a member
of the Committee.

            (b)  Rule  16b-3  Limitations.  Notwithstanding  the  provisions  of
Subsection  (a) of this  Section  13, in the event that Rule  16b-3  promulgated
under the Securities  Exchange Act of 1934, as amended (the "Exchange  Act"), or
any successor  provision ("Rule 16b-3") provides  specific  requirements for the
administrators  of plans of this type,  the Plan shall be only  administered  by
such a


                                       -6-

<PAGE>



body and in such a manner as shall comply with the  applicable  requirements  of
Rule 16b-3. Unless permitted by Rule 16b-3, no discretion  concerning  decisions
regarding  the Plan shall be  afforded  to any  committee  or person that is not
"disinterested" as that term is used in Rule 16b-3.

         14. Designation of Beneficiary.

            (a) A participant  may file a written  designation  of a beneficiary
who is to receive any shares and cash,  if any, from the  participant's  account
under  the Plan in the  event of such  parti  cipant's  death  subsequent  to an
Exercise  Date on which the option is  exercised  but prior to  delivery to such
participant  of such shares and cash.  In  addition,  a  participant  may file a
written  designation  of a  beneficiary  who is to  receive  any  cash  from the
participant's  account under the Plan in the event of such  participant's  death
prior to exercise of the option.  If a participant is married and the designated
beneficiary  is not the  spouse,  spousal  consent  shall be  required  for such
designation to be effective.

            (b)  Such   designation  of  beneficiary   may  be  changed  by  the
participant  at any time by  written  notice.  In the  event  of the  death of a
participant  and in the absence of a beneficiary  validly  designated  under the
Plan who is living at the time of such  participant's  death,  the Company shall
deliver such shares and/or cash to the executor or  administrator  of the estate
of the participant,  or if no such executor or administrator  has been appointed
(to the knowledge of the Company),  the Company, in its discretion,  may deliver
such  shares  and/or  cash to the  spouse  or to any one or more  dependents  or
relatives of the participant, or if no spouse, dependent or relative is known to
the Company, then to such other person as the Company may designate.

         15.   Transferability.   Neither  payroll  deductions   credited  to  a
participant's account nor any rights with regard to the exercise of an option or
to  receive  shares  under the Plan may be  assigned,  transferred,  pledged  or
otherwise  disposed of in any way (other  than by will,  the laws of descent and
distribution or as provided in Section 14 hereof) by the  participant.  Any such
attempt at assignment,  transfer,  pledge or other  disposition shall be without
effect,  except  that the  Company may treat such act as an election to withdraw
funds from an Offering Period in accordance with Section 10 hereof.

         16.  Use of  Funds.  All  payroll  deductions  received  or held by the
Company under the Plan may be used by the Company for any corporate purpose, and
the Company shall not be obligated to segregate such payroll deductions.

         17.   Reports.   Individual   accounts  will  be  maintained  for  each
participant  in the Plan.  Statements of account will be given to  participating
Employees  at least  annually,  which  statements  will set forth the amounts of
payroll  deductions,  the Purchase Price, the number of shares purchased and the
remaining cash balance, if any.

         18. Adjustments Upon Changes in Capitalization.

            (a) Changes in Capitalization. Subject to any required action by the
stockholders  of the  Company,  the  Reserves  as well as the price per share of
Common  Stock  covered  by each  option  under  the Plan  which has not yet been
exercised shall be proportionately adjusted for any


                                       -7-

<PAGE>



increase or decrease in the number of issued  shares of Common  Stock  resulting
from a  stock  split,  reverse  stock  split,  stock  dividend,  combination  or
reclassification  of the Common Stock,  or any other increase or decrease in the
number of shares of Common Stock effected  without receipt of  consideration  by
the Company; provided, however, that conversion of any convertible securities of
the  Company  shall  not be deemed to have been  "effected  without  receipt  of
consideration".  Such adjustment shall be made by the Board, whose determination
in that  respect  shall be final,  binding and  conclusive.  Except as expressly
provided herein,  no issuance by the Company of shares of stock of any class, or
securities  convertible into shares of stock of any class,  shall affect, and no
adjustment by reason  thereof shall be made with respect to, the number or price
of shares of Common Stock subject to an option.

            (b)  Dissolution  or  Liquidation.  In the  event  of  the  proposed
dissolution or liquidation  of the Company,  the Offering  Period will terminate
immediately prior to the consummation of such proposed action,  unless otherwise
provided by the Board.

            (c) Merger or Asset Sale.  In the event of a proposed sale of all or
substantially  all of the assets of the  Company,  or the merger of the  Company
with or into another corporation, each option under the Plan shall be assumed or
an equivalent  option shall be substituted  by such  successor  corporation or a
parent or subsidiary of such successor corporation, unless the Board determines,
in the  exercise  of its  sole  discretion  and in lieu of  such  assumption  or
substitution,  to shorten the Offering  Period then in progress by setting a new
Exercise Date (the "New Exercise Date") or to cancel each  outstanding  right to
purchase and refund all sums  collected  from  participants  during the Offering
Period then in  progress.  If the Board  shortens  the  Offering  Period then in
progress in lieu of assumption or  substitution in the event of a merger or sale
of assets, the Board shall notify each participant in writing, at least ten (10)
business  days prior to the New Exercise  Date,  that the Exercise  Date for his
option has been  changed to the New  Exercise  Date and that his option  will be
exercised  automatically on the New Exercise Date,  unless prior to such date he
has  withdrawn  from the Offering  Period as provided in Section 10 hereof.  For
purposes of this paragraph,  an option granted under the Plan shall be deemed to
be assumed if,  following the sale of assets or merger,  the option  confers the
right to  purchase,  for each  share  of  option  stock  subject  to the  option
immediately prior to the sale of assets or merger,  the  consideration  (whether
stock,  cash or other securities or property)  received in the sale of assets or
merger by  holders of Common  Stock for each  share of Common  Stock held on the
effective date of the transaction  (and if such holders were offered a choice of
consideration,  the type of consideration chosen by the holders of a majority of
the  outstanding  shares  of  Common  Stock);  provided,  however,  that if such
consideration  received  in the sale of assets or merger was not  solely  common
stock of the successor  corporation  or its parent (as defined in Section 424(e)
of the Code),  the Board may, with the consent of the successor  corporation and
the participant,  provide for the  consideration to be received upon exercise of
the option to be solely common stock of the successor  corporation or its parent
equal in fair market value to the per share consideration received by holders of
Common Stock and the sale of assets or merger.

         The  Board  may,  if it so  determines  in the  exercise  of  its  sole
discretion, also make provision for adjusting the Reserves, as well as the price
per share of Common Stock covered by each out standing option,  in the event the
Company effects one or more reorganizations, recapitalization, rights


                                       -8-

<PAGE>



offerings or other increases or reductions of shares of its  outstanding  Common
Stock,  and in the event of the Company being  consolidated  with or merged into
any other corporation.

         19. Amendment or Termination.

            (a) The Board of  Directors  of the  Company may at any time and for
any reason terminate or amend the Plan. Except as provided in Section 18 hereof,
no such  termination  can affect options  previously  granted,  provided that an
Offering Period may be terminated by the Board of Directors on any Exercise Date
if the  Board  determines  that  the  termination  of the  Plan  is in the  best
interests of the Company and its stockholders.  Except as provided in Section 18
hereof, no amendment may make any change in any option theretofore granted which
adversely  affects the rights of any  participant.  To the extent  necessary  to
comply with Rule 16b-3 or under Section 423 of the Code (or any  successor  rule
or provision  or any other  applicable  law or  regulation),  the Company  shall
obtain shareholder approval in such a manner and to such a degree as required.

            (b) Without  shareholder  consent and without  regard to whether any
participant  rights may be considered  to have been  "adversely  affected,"  the
Board (or its  committee)  shall be  entitled  to change the  Offering  Periods,
establish the exchange ratio  applicable to amounts withheld in a currency other
than U.S. dollars, permit payroll withholding in excess of the amount designated
by a  participant  in order to adjust for delays or  mistakes  in the  Company's
processing of properly completed  withholding  elections,  establish  reasonable
waiting and  adjustment  periods and/or  accounting and crediting  procedures to
ensure  that  amounts  applied  toward  the  purchase  of Common  Stock for each
participant  properly  correspond with amounts  withheld from the  participant's
Compensation,  and establish  such other  limitations or procedures as the Board
(or its  committee)  determines  in its  sole  discretion  advisable  which  are
consistent with the Plan.

         20. Notices.  All notices or other  communications  by a participant to
the Company  under or in  connection  with the Plan shall be deemed to have been
duly given when  received in the form  specified by the Company at the location,
or by the person, designated by the Company for the receipt thereof.

         21. Conditions Upon Issuance of Shares. Shares shall not be issued with
respect to an option  unless the  exercise of such option and the  issuance  and
delivery of such  shares  pursuant  thereto  shall  comply  with all  applicable
provisions  of law,  domestic or foreign,  including,  without  limitation,  the
Securities  Act of 1933,  as amended,  the  Securities  Exchange Act of 1934, as
amended, the rules and regulations promulgated thereunder,  and the requirements
of any stock  exchange  upon which the  shares may then be listed,  and shall be
further  subject to the approval of counsel for the Company with respect to such
compliance.

         As a condition  to the  exercise of an option,  the Company may require
the person  exercising  such option to represent  and warrant at the time of any
such  exercise  that the  shares are being  purchased  only for  investment  and
without  any  present  intention  to sell or  distribute  such shares if, in the
opinion of counsel for the Company,  such a representation is required by any of
the aforementioned applicable provisions of law.


                                       -9-

<PAGE>



         22. Term of Plan.  The Plan shall become  effective upon the earlier to
occur  of its  adoption  by the  Board  of  Directors  or  its  approval  by the
stockholders of the Company.  It shall continue in effect for a term of ten (10)
years unless sooner terminated under Section 19 hereof.

         23. Additional  Restrictions of Rule 16b-3. The terms and conditions of
options granted  hereunder to, and the purchase of shares by, persons subject to
Section 16 of the Exchange Act shall comply with the  applicable  provisions  of
Rule  16b-3.  This Plan  shall be  deemed to  contain,  and such  options  shall
contain,  and the shares issued upon exercise  thereof shall be subject to, such
additional  conditions  and  restrictions  as may be  required  by Rule 16b-3 to
qualify for the  maximum  exemption  from  Section 16 of the  Exchange  Act with
respect to Plan transactions.



                                      -10-

<PAGE>



                                    Exhibit A


                             CHOLESTECH CORPORATION

                        1992 EMPLOYEE STOCK PURCHASE PLAN

                             SUBSCRIPTION AGREEMENT



_____ Original Application                           Enrollment Date: __________
_____ Change in Payroll Deduction Rate
_____ Change of Beneficiary(ies)


1.       _____________________________________  hereby elects to  participate in
         the  Cholestech  Corporation  1992  Employee  Stock  Purchase Plan (the
         "Employee  Stock Purchase  Plan") and subscribes to purchase  shares of
         the  Company's  Common  Stock  in  accordance  with  this  Subscription
         Agreement and the Employee Stock Purchase Plan.

2.       I hereby authorize payroll  deductions from each paycheck in the amount
         of ____% of my  Compensation  on each payday (not to exceed 15%) during
         the Offering  Period in  accordance  with the Employee  Stock  Purchase
         Plan. (Please note that no fractional percentages are permitted.)

3.       I understand that said payroll  deductions shall be accumulated for the
         purchase of shares of Common  Stock at the  applicable  Purchase  Price
         determined  in  accordance  with the Employee  Stock  Purchase  Plan. I
         understand  that if I do not  withdraw  from an  Offering  Period,  any
         accumulated  payroll deductions will be used to automatically  exercise
         my option.

4.       I have  received a copy of the complete  "Cholestech  Corporation  1992
         Employee Stock Purchase  Plan." I understand that my  participation  in
         the Employee  Stock  Purchase  Plan is in all  respects  subject to the
         terms of the Plan.  I  understand  that the grant of the  option by the
         Company  under this  Subscription  Agreement  is  subject to  obtaining
         shareholder approval of the Employee Stock Purchase Plan.

         5. Shares  purchased  for me under the  Employee  Stock  Purchase  Plan
         should be issued in the name(s) of  (Employee  or  Employee  and Spouse
         Only):

6.       I understand that if I dispose of any shares received by me pursuant to
         the Plan within 2 years after the Enrollment Date (the first day of the
         Offering  Period  during  which I  purchased  such  shares),  I will be
         treated for federal  income tax  purposes as having  received  ordinary
         income at the time of such disposition in an amount equal to the excess
         of the fair market value of the


                                    

<PAGE>



         shares  at the time such  shares  were  delivered  to me over the price
         which I paid for the  shares.  I hereby  agree to notify the Company in
         writing within 30 days after the date of any  disposition of shares and
         I will  make  adequate  provision  for  Federal,  state  or  other  tax
         withholding  obligations,  if any, which arise upon the  disposition of
         the Common  Stock.  The  Company  may,  but will not be  obligated  to,
         withhold  from  my  compensation  the  amount  necessary  to  meet  any
         applicable  withholding  obligation including any withholding necessary
         to make  available  to the  Company  any  tax  deductions  or  benefits
         attributable  to sale or early  disposition of Common Stock by me. If I
         dispose of such shares at any time after the  expiration  of the 2-year
         holding period,  I understand that I will be treated for federal income
         tax  purposes  as  having  received  income  only  at the  time of such
         disposition, and that such income will be taxed as ordinary income only
         to the extent of an amount equal to the lesser of (1) the excess of the
         fair market  value of the shares at the time of such  disposition  over
         the purchase price which I paid for the shares,  or (2) 15% of the fair
         market value of the shares on the first day of the Offering Period. The
         remainder of the gain, if any,  recognized on such  disposition will be
         taxed as capital gain.

7.       I hereby agree to be bound by the terms of the Employee  Stock Purchase
         Plan. The  effectiveness  of this  Subscription  Agreement is dependent
         upon my eligibility to participate in the Employee Stock Purchase Plan.

8.       In the  event of my  death,  I hereby  designate  the  following  as my
         beneficiary(ies)  to receive all  payments  and shares due me under the
         Employee Stock Purchase Plan:



NAME:  (Please print)___________________________________________________________
                                      (First        (Middle)        (Last)



_____________________               ____________________________________________
Relationship
                                    ____________________________________________
                                    (Address)





                                       -2-

<PAGE>




NAME:  (Please print)___________________________________________________________
                                      (First        (Middle)        (Last)



_____________________               ____________________________________________
Relationship
                                    ____________________________________________
                                    (Address)



Employee's Social
Security Number:                    ____________________________________________



Employee's Address:                 ____________________________________________

                                    ____________________________________________

                                    ____________________________________________


I UNDERSTAND THAT THIS SUBSCRIPTION  AGREEMENT SHALL REMAIN IN EFFECT THROUGHOUT
SUCCESSIVE OFFERING PERIODS UNLESS TERMINATED BY ME.



Dated:_______________                                ___________________________
                                                     Signature of Employee



                                                     ___________________________
                                                      Spouse's   Signature   (If
                                                      beneficiary   other   than
                                                      spouse)





                                       -3-

<PAGE>


                                    Exhibit B


                             CHOLESTECH CORPORATION

                        1992 EMPLOYEE STOCK PURCHASE PLAN

                              NOTICE OF WITHDRAWAL


         The  undersigned  participant in the Offering  Period of the Cholestech
Corporation 1992 Employee Stock Purchase Plan which began on ___________  19____
(the  "Enrollment  Date")  hereby  notifies  the  Company  that he or she hereby
withdraws from the Offering Period.  He or she hereby directs the Company to pay
to the  undersigned  as  promptly  as  practicable  all the  payroll  deductions
credited  to his or her  account  with  respect  to such  Offering  Period.  The
undersigned  understands  and agrees  that his or her  option for such  Offering
Period will be automatically  terminated.  The undersigned  understands  further
that no further  payroll  deductions  will be made for the purchase of shares in
the current Offering Period and the undersigned shall be eligible to participate
in  succeeding  Offering  Periods  only  by  delivering  to  the  Company  a new
Subscription Agreement.


                                                Name and Address of Participant:

                                                ________________________________

                                                ________________________________

                                                ________________________________



                                                Signature:

                                                ________________________________


                                                Date:___________________________


                         Wilson Sonsini Goodrich & Rosati            Exhibit 5.1
                               650 Page Mill Road
                               Palo Alto, CA 94304
                                 (415) 493-9300


                                October 17, 1997


Cholestech Corporation
3347 Investment Boulevard
Hayward, California 94545

Ladies and Gentlemen:

     We have examined the Registration  Statement on Form S-8 to be filed by you
with the  Securities  and Exchange  Commission  on or about October 17, 1997, in
connection with the  registration  under the Securities Act of 1933, as amended,
of an aggregate of 200,000  additional  shares of your Common Stock reserved for
issuance under the 1992 Employee Stock Purchase Plan (the "1992 Plan").

     As your legal  counsel,  we have  examined  the  proceedings  taken and are
familiar with the proceedings proposed to be taken by you in connection with the
sale and issuance of said shares. It is our opinion that the additional  shares,
when issued and sold in the manner  referred to in the 1992 Plan and pursuant to
the  agreements  which  accompany  the 1992 Plan,  will be legally  and  validly
issued, fully paid and nonassessable.

     We  consent to the use of this  opinion as an exhibit to said  Registration
Statement and further consent to the use of our name wherever  appearing in said
Registration Statement and any amendments thereto.


                                            Sincerely,

                                            WILSON SONSINI GOODRICH & ROSATI
                                            Professional Corporation

                                            /s/ WILSON SONSINI GOODRICH & ROSATI


                                       -6-


                                                                    Exhibit 23.1


                       CONSENT OF INDEPENDENT ACCOUNTANTS


We  hereby  consent  to the  incorporation  by  reference  in this  Registration
Statement on Form S-8 of our report  dated April 24, 1997  appearing on page F-2
of Cholestech  Corporation's Annual Report on Form 10-K for the year ended March
28, 1997.



/s/ Price Waterhouse LLP

PRICE WATERHOUSE LLP
San Jose, California
October 16, 1997
                                       -7-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission